Log on / register
Feedback | Support | My details
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.
Somoskovi A, Parsons LM, Salfinger M
Respir Res 2001, 2:164-8
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.
Mariam DH, Mengistu Y, Hoffner SE, Andersson DI
Antimicrob Agents Chemother 2004 Apr, 48:1289-94
 [PubMed Central] [PubMed] [Related articles]
2.
Detection and identification of Mycobacterium tuberculosis in joint biopsy specimens by rpoB PCR cloning and sequencing.
Yun YJ, Lee KH, Haihua L, Ryu YJ, Kim BJ, Lee YH, Baek GH, Kim HJ, Chung MS, Lee MC, Lee SH, Choi IH, Cho TJ, Chang BS, Kook YH
J Clin Microbiol 2005 Jan, 43:174-8
 [PubMed Central] [PubMed] [Related articles]
3.
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.
Parsons LM, Salfinger M, Clobridge A, Dormandy J, Mirabello L, Polletta VL, Sanic A, Sinyavskiy O, Larsen SC, Driscoll J, Zickas G, Taber HW
Antimicrob Agents Chemother 2005 Jun, 49:2218-25
 [PubMed Central] [PubMed] [Related articles]
4.
Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.
Viveiros M, Leandro C, Rodrigues L, Almeida J, Bettencourt R, Couto I, Carrilho L, Diogo J, Fonseca A, Lito L, Lopes J, Pacheco T, Pessanha M, Quirim J, Sancho L, Salfinger M, Amaral L
J Clin Microbiol 2005 Sep, 43:4880-4
 [PubMed Central] [PubMed] [Related articles]
5.
Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M
J Clin Microbiol 2006 Dec, 44:4459-63
 [PubMed Central] [PubMed] [Related articles]
6.
A Case of Acquired Rifampin Resistance in Mycobacterium Bovis Bacillus Calmette-Guérin-induced Cystitis: Necessity for Treatment Guidelines.
Wolfe JN, Blackwood-Antonation KS, Sharma MK, Cook VJ
Can J Infect Dis Med Microbiol 2006 May, 17:183-5
 [PubMed Central] [PubMed] [Related articles]
7.
Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.
Gumbo T, Louie A, Deziel MR, Liu W, Parsons LM, Salfinger M, Drusano GL
Antimicrob Agents Chemother 2007 Nov, 51:3781-8
 [PubMed Central] [PubMed] [Related articles]
8.
Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis.
Bergval IL, Vijzelaar RN, Dalla Costa ER, Schuitema AR, Oskam L, Kritski AL, Klatser PR, Anthony RM
J Clin Microbiol 2008 Feb, 46:689-99
 [PubMed Central] [PubMed] [Related articles]
9.
GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.
Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, Rosés S, Maldonado J, Domínguez J
J Clin Microbiol 2008 Nov, 46:3660-7
 [PubMed Central] [PubMed] [Related articles]
10.
Comparison of the performances of two in-house rapid methods for antitubercular drug susceptibility testing.
de la Iglesia AI, Stella EJ, Morbidoni HR
Antimicrob Agents Chemother 2009 Feb, 53:808-10
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.